Skip to main content

Peer Review reports

From: Evolution of therapeutic management of patients with ANCA associated vasculitis in France after licensing Rituximab use

Original Submission
24 Nov 2023 Submitted Original manuscript
30 Nov 2023 Author responded Author comments - Aurélie Schmidt
30 Jan 2024 Reviewed Reviewer Report - Anna Masiak
20 Feb 2024 Reviewed Reviewer Report - Bernhard Nolle
5 Mar 2024 Author responded Author comments - Aurélie Schmidt
Resubmission - Version 2
30 Nov 2023 Submitted Manuscript version 2
11 Mar 2024 Author responded Author comments - Aurélie Schmidt
Resubmission - Version 3
11 Mar 2024 Submitted Manuscript version 3
1 Apr 2024 Reviewed Reviewer Report - Bernhard Nolle
8 Apr 2024 Author responded Author comments - Aurélie Schmidt
Resubmission - Version 4
8 Apr 2024 Submitted Manuscript version 4
Publishing
10 Apr 2024 Editorially accepted
28 Apr 2024 Article published 10.1186/s41927-024-00385-8

You can find further information about peer review here.

Back to article page